- $1.05bn
- $1.32bn
- $2.01bn
- 60
- 78
- 95
- 92
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 7.81 | ||
| PEG Ratio (f) | 0.22 | ||
| EPS Growth (f) | 53.45% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.37 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 5.7 | ||
| Price to Sales | 0.52 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -4% | ||
| Return on Equity | -12.28% | ||
| Operating Margin | -3.41% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1,733.95 | 1,911.19 | 1,972.02 | 1,994.64 | 2,012.92 | 1,863.88 | 1,915.59 | 2.49% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -55.27 | +236.61 | -2.26 | -59.49 | +27.1 | +97.72 | +5.38 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Pediatrix Medical Group, Inc. is a provider of physician services, including newborn, maternal-fetal, and other pediatric subspecialty care. The Company’s affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by pediatric subspecialties. It offers specialized and critical care services through approximately 4,400 affiliated physicians and other clinicians. It provides neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. The Company provides maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.
Directors
- Guy Sansone NEC (56)
- Mark Ordan CEO
- C. Marc Richards CFO (50)
- Roger Hinson CEX (57)
- Dominic Andreano EVP (52)
- Mary Ann Moore EVP
- John Pepia SVP (58)
- Manuel Kadre LED (55)
- Roger Medel DRC (74)
- Karey Barker IND (53)
- Waldemar Carlo IND (68)
- Paul Gabos IND (55)
- Thomas McEachin IND (68)
- Michael Rucker IND (51)
- John Starcher IND (50)
- Shirley Weis IND (67)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- October 10th, 2007
- Public Since
- September 20th, 1995
- No. of Shareholders
- 163
- No. of Employees
- 2,150
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
New York Stock Exchange- Shares in Issue
- 85,829,575
- Address
- 1301 CONCORD TERRACE, SUNRISE, 33323
- Web
- https://www.pediatrix.com/
- Phone
- +1 9543840175
- Contact
- Kasandra Rossi
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for MD
Q1 2025 Pediatrix Medical Group Inc Earnings Call
Pediatrix Medical Group Inc Annual Shareholders Meeting
Pediatrix Medical Group Inc Annual Shareholders Meeting
Q2 2025 Pediatrix Medical Group Inc Earnings Release
Similar to MD
Agilon Health
New York Stock Exchange
AMERICAN WELL
New York Stock Exchange
AMN Healthcare Services
New York Stock Exchange
Ardent Health Partners
New York Stock Exchange
Auna SA
New York Stock Exchange
FAQ
What is the Pediatrix Medical share price?
As of Today at 22:35 UTC, shares in Pediatrix Medical are trading at $12.25. This share price information is delayed by 15 minutes.
How has the Pediatrix Medical share price performed this year?
Shares in Pediatrix Medical last closed at $12.25 and the price had moved by +37.64% over the past 365 days. In terms of relative price strength the Pediatrix Medical share price has outperformed the S&P500 Index by +27.05% over the past year.
What are the analyst and broker recommendations for Pediatrix Medical?
The overall consensus recommendation for Pediatrix Medical is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Pediatrix Medical dividend yield?
Pediatrix Medical does not currently pay a dividend.
Does Pediatrix Medical pay a dividend?
Pediatrix Medical does not currently pay a dividend.
When does Pediatrix Medical next pay dividends?
Pediatrix Medical does not currently pay a dividend.
How do I buy Pediatrix Medical shares?
To buy shares in Pediatrix Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Pediatrix Medical?
As of the previous close price of $12.25, shares in Pediatrix Medical had a market capitalisation of $1.05bn.
Where are Pediatrix Medical shares listed?
Here are the trading details for Pediatrix Medical:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: MD
What kind of share is Pediatrix Medical?
Based on an overall assessment of its quality, value and momentum Pediatrix Medical is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Pediatrix Medical share price forecast for 2025?
The analyst consensus target price for shares in Pediatrix Medical is $18.07. That is 47.51% above the last closing price of $12.25.
Analysts covering Pediatrix Medical currently have a consensus Earnings Per Share (EPS) forecast of $1.54 for the next financial year.
Find out moreWhat is the trend in the Pediatrix Medical share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pediatrix Medical. Over the past six months, its share price has outperformed the S&P500 Index by +4.04%.
As of the last closing price of $12.25, shares in Pediatrix Medical were trading -3.38% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Pediatrix Medical PE Ratio?
The Pediatrix Medical PE ratio based on its reported earnings over the past 12 months is 7.81. The shares last closed at $12.25.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Pediatrix Medical?
Pediatrix Medical's management team is headed by:
- Guy Sansone - NEC
- Mark Ordan - CEO
- C. Marc Richards - CFO
- Roger Hinson - CEX
- Dominic Andreano - EVP
- Mary Ann Moore - EVP
- John Pepia - SVP
- Manuel Kadre - LED
- Roger Medel - DRC
- Karey Barker - IND
- Waldemar Carlo - IND
- Paul Gabos - IND
- Thomas McEachin - IND
- Michael Rucker - IND
- John Starcher - IND
- Shirley Weis - IND